BACKGROUND:Transcutaneous low-level tragus electrical stimulation (LLTS) suppresses atrial fibrillation (AF) in canines. OBJECTIVES: This study examined the antiarrhythmic and anti-inflammatory effects of LLTS in humans. METHODS:Patients with paroxysmal AF who presented for AF ablation were randomized to either 1 h of LLTS (n = 20) or sham control (n = 20). Attaching a flat metal clip onto the tragus produced LLTS (20 Hz) in the right ear (50% lower than the voltage slowing the sinus rate). Under general anesthesia, AF was induced by burst atrial pacing at baseline and after 1 h of LLTS or sham treatment. Blood samples from the coronary sinus and the femoral vein were collected at those time points and then analyzed for inflammatory cytokines, including tumor necrosis factor alpha and C-reactive protein, using a multiplex immunoassay. RESULTS: There were no differences in baseline characteristics between the 2 groups. Pacing-induced AF duration decreased significantly by 6.3 ± 1.9 min compared with baseline in the LLTS group, but not in the control subjects (p = 0.002 for comparison between groups). AF cycle length increased significantly from baseline by 28.8 ± 6.5 ms in the LLTS group, but not in control subjects (p = 0.0002 for comparison between groups). Systemic (femoral vein) but not coronary sinus tumor necrosis factor (TNF)-alpha and C-reactive protein levels decreased significantly only in the LLTS group. CONCLUSIONS:LLTS suppresses AF and decreases inflammatory cytokines in patients with paroxysmal AF. Our results support the emerging paradigm of neuromodulation to treat AF.
RCT Entities:
BACKGROUND: Transcutaneous low-level tragus electrical stimulation (LLTS) suppresses atrial fibrillation (AF) in canines. OBJECTIVES: This study examined the antiarrhythmic and anti-inflammatory effects of LLTS in humans. METHODS:Patients with paroxysmal AF who presented for AF ablation were randomized to either 1 h of LLTS (n = 20) or sham control (n = 20). Attaching a flat metal clip onto the tragus produced LLTS (20 Hz) in the right ear (50% lower than the voltage slowing the sinus rate). Under general anesthesia, AF was induced by burst atrial pacing at baseline and after 1 h of LLTS or sham treatment. Blood samples from the coronary sinus and the femoral vein were collected at those time points and then analyzed for inflammatory cytokines, including tumor necrosis factor alpha and C-reactive protein, using a multiplex immunoassay. RESULTS: There were no differences in baseline characteristics between the 2 groups. Pacing-induced AF duration decreased significantly by 6.3 ± 1.9 min compared with baseline in the LLTS group, but not in the control subjects (p = 0.002 for comparison between groups). AF cycle length increased significantly from baseline by 28.8 ± 6.5 ms in the LLTS group, but not in control subjects (p = 0.0002 for comparison between groups). Systemic (femoral vein) but not coronary sinus tumor necrosis factor (TNF)-alpha and C-reactive protein levels decreased significantly only in the LLTS group. CONCLUSIONS: LLTS suppresses AF and decreases inflammatory cytokines in patients with paroxysmal AF. Our results support the emerging paradigm of neuromodulation to treat AF.
Authors: Yoko Miyasaka; Marion E Barnes; Bernard J Gersh; Stephen S Cha; Kent R Bailey; Walter P Abhayaratna; James B Seward; Teresa S M Tsang Journal: Circulation Date: 2006-07-03 Impact factor: 29.690
Authors: Valentin Fuster; Lars E Rydén; David S Cannom; Harry J Crijns; Anne B Curtis; Kenneth A Ellenbogen; Jonathan L Halperin; Jean-Yves Le Heuzey; G Neal Kay; James E Lowe; S Bertil Olsson; Eric N Prystowsky; Juan Luis Tamargo; Samuel Wann; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffery L Anderson; Elliott M Antman; Sharon Ann Hunt; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel; Silvia G Priori; Jean-Jacques Blanc; Andrzej Budaj; A John Camm; Veronica Dean; Jaap W Deckers; Catherine Despres; Kenneth Dickstein; John Lekakis; Keith McGregor; Marco Metra; Joao Morais; Ady Osterspey; José Luis Zamorano Journal: J Am Coll Cardiol Date: 2006-08-15 Impact factor: 24.094
Authors: Eugene Patterson; Ralph Lazzara; Bela Szabo; Hong Liu; David Tang; Yu-Hua Li; Benjamin J Scherlag; Sunny S Po Journal: J Am Coll Cardiol Date: 2006-02-23 Impact factor: 24.094
Authors: Jared M Huston; Margot Gallowitsch-Puerta; Mahendar Ochani; Kanta Ochani; Renqi Yuan; Mauricio Rosas-Ballina; Mala Ashok; Richard S Goldstein; Sangeeta Chavan; Valentin A Pavlov; Christine N Metz; Huan Yang; Christopher J Czura; Haichao Wang; Kevin J Tracey Journal: Crit Care Med Date: 2007-12 Impact factor: 7.598
Authors: Youhua Zhang; Zoran B Popovic; Steve Bibevski; Itaf Fakhry; Domenic A Sica; David R Van Wagoner; Todor N Mazgalev Journal: Circ Heart Fail Date: 2009-09-22 Impact factor: 8.790
Authors: Yuan Yuan; Jonathan L Hassel; Anisiia Doytchinova; David Adams; Keith C Wright; Chad Meshberger; Lan S Chen; Maria P Guerra; Changyu Shen; Shien-Fong Lin; Thomas H Everett; Vicenta Salanova; Peng-Sheng Chen Journal: Heart Rhythm Date: 2017-08-01 Impact factor: 6.343
Authors: Liping Zhou; Adrian Filiberti; Mary Beth Humphrey; Christian D Fleming; Benjamin J Scherlag; Sunny S Po; Stavros Stavrakis Journal: Exp Physiol Date: 2018-11-29 Impact factor: 2.969
Authors: Yuan Yuan; Zhaolei Jiang; Ye Zhao; Wei-Chung Tsai; Jheel Patel; Lan S Chen; Changyu Shen; Shien-Fong Lin; Huei-Sheng Vincent Chen; Thomas H Everett; Michael C Fishbein; Zhenhui Chen; Peng-Sheng Chen Journal: Heart Rhythm Date: 2017-11-27 Impact factor: 6.343
Authors: Yuan Yuan; Xiao Liu; Juyi Wan; Johnson Wong; Amanda A Bedwell; Scott A Persohn; Changyu Shen; Michael C Fishbein; Lan S Chen; Zhenhui Chen; Thomas H Everett; Paul R Territo; Peng-Sheng Chen Journal: Heart Rhythm Date: 2019-05-29 Impact factor: 6.343
Authors: Jeffrey L Ardell; Heath Nier; Matthew Hammer; E Marie Southerland; Christopher L Ardell; Eric Beaumont; Bruce H KenKnight; J Andrew Armour Journal: J Physiol Date: 2017-09-30 Impact factor: 5.182